Tabuk and cumberland partner to bring innovative antibiotic with life-saving potential to middle east

Vibativ ®  treats patients with multidrug-resistant infections nashville, tenn. and riyadh, saudi arabia, march 31, 2022 /prnewswire/ -- specialty pharmaceutical companies cumberland pharmaceuticals inc. (nasdaq: cpix), headquartered in nashville, and tabuk pharmaceutical manufacturing co mpany , a fully owned subsidiary of astra industrial group and a leading pharmaceutical company in the middle east, headquartered in riyadh, saudi arabia, today announced the launch of cumberland's vibativ® (telavancin) injection in the middle east.
CPIX Ratings Summary
CPIX Quant Ranking